Research & Clinical Trials
As a Texas Urology Specialists patient, you may have the opportunity to receive newly-developed treatments or investigational drugs through participation in clinical trials. Although they are unproven, new treatments and drugs may result in the alleviation of your symptoms.
To receive these experimental treatments, you will likely be required to participate in research studies or clinical trials. These clinical trials are designed to evaluate new treatment options as part of a deliberate and comprehensive research process that often takes years. Clinical trials test the safety and effectiveness of new or modified treatments in patients using new drugs, unique approaches to surgery and radiation therapy, or various combinations of treatments.
If you are interested in learning more about Research and Clinical Trials and if you qualify, please review the list of available trials below and discuss those options with your Texas Oncology Physician.
PrTK03 Combination w. Radiation
The purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect.
PrTK04 Ulysses Active Surveillance
The purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in patients undergoing active surveillance for localized prostate cancer. ProstAtak® involves the use of aglatimagene besadenovec (AdV-tk) to kill tumor cells and stimulate a cancer vaccine effect.